Inoculation of phorbol ester-differentiated U937 cells as a model for human macrophages with Chlamydia trachomatis of the urogenital serovar K resulted in a persistent infection, with maximal growth at day 7, until day 10 post-infection. At these times inclusion bodies were present in 0.5-2% of the cells. Typical inclusion bodies containing elementary bodies and reticulate bodies were observed by electron microscopy. Furthermore, single chlamydial particles resembling atypical elementary or intermediate bodies were identified in the cytoplasm in > 80% of the host cells. IFN-y exerts antichlamydial activity in epithelial and fibroblastoid cells, but the infection of U937 cells by C. trachomatis was not affected by IFN-y. The activity of the tryptophandegrading enzyme indoleamine 2,3-dioxygenase (IDO) was not detected in untreated or in IFN-y-treated or chlamydiae-infected or mock-infected U937 cells. The presence of atypical persisting chlamydiae and the lack of I D 0 expression in U937 cells indicates that the development of these atypical bacteria is independent from IFN-y-mediated tryptophan deprivation and other IFN-y-mediated effects. Evaluation of persistently infected cells revealed that the expression of the chlamydial major outer-membrane protein, heat-shock protein (hsp60) and lipopolysaccharide (LPS) antigens was not significantly altered in the course of the culture. An intense staining of the LPS on the surface of the host cells was demonstrated by immunofluorescence. The data show that phorbol ester-differentiated U937 cells restrict chlamydial growth strongly but not completely through a mechanism distinct from IDO-mediated tryptophan deprivation. The mechanisms of persistence of chlamydiae in monocytes, which differ considerably from those described for other cells, require further investigation.
Introduction
The obligate intracellular bacterium Chlamydia trachomatis exhibits a complex developmental cycle involving an infectious metabolically inactive form (elementary body: EB) and a non-infectious metabolically active form (reticulate body: RI3) [l] . One characteristic of the biovar trachoma is its capacity to induce chronic diseases such as blinding trachoma orafter urogenital infection -complications like infertility or ectopic pregnancy [2-41. Moreover, C. trachomatis of the serovars D-K have also been implicated in Reiter's disease and chlamydia-induced arthritis [ 5 , 61 .
The pathogenesis of the extra-urogenital chronic sequelae of chlamydial infections is not well understood. One important observation is that C. trachomatis persists at the site of inflammation in a viable but culture-negative state [7, 81. Chlamydia1 antigen has been detected in specimens from patients with active trachoma, even though chlamydiae could not be isolated by culture [9] . Chlamydia major outer membrane protein (MOMP), lipopolysaccharide (LPS) and rRNA have been identified in culturenegative specimens from inflamed joints of patients with chlamydia-induced arthritis and Reiter's syndrome [5, 10-121. Although the target cells for the trachoma biovar are preferentially mucosal epithelial cells, published data show the persistence of chlamydiae in monocytic cells [ 13 -151. Recently, Nanagara et al. demonstrated chlamydiae in both macrophages and fibroblasts from synovial membranes from patients with Reiter's disease some 12 years after the onset of the disease [ 81. These observations suggest that persistent infection of monocytes may be relevant for the pathogenic process leading to chronic chlamydiainduced inflammatory disease.
An earlier study showed that morphologically altered but metabolically active C. trachomatis serotype K persists in human peripheral blood monocytes for 14 days post-infection in vitro [13, 161 . The in-vitro infection of monocytes possibly reflects one basic mechanism of chronic chlamydial inflammation at the cellular level. However, the use of these cells to investigate the basic intracellular events in chlamydiamediated persistence has several limitations. The methods of preparation and separation do not exclude contamination with lymphocytes, only a limited number of cells can be obtained from one blood donor, and monocytes may vary according to the biological variability of the blood donors. The establishment of an in-vitro infection model with monocytic phorbol ester-treated U937 cells could therefore serve as an alternative tool to study the mechanisms of chlamydial persistence [ 171.
The aim of this study was to investigate the fate of C.
trachomatis serovar K in differentiated U937 cells and the influence of IFN-y. This cytokine induces persistence of chlamydiae in fibroblasts and epithelial cells [18] [19] [20] . Because persistent chlamydial infections have been proposed as a source of antigens that induces or maintains the chronic inflammatory diseases or both, the levels of chlamydial immunogens were evaluated during the course of chlamydial infection of U937 cells [21, 221. 
Materials and methods
Preparation of bacteria C. trachomatis serovar K (UWl3 1ICx; Washington Research Foundation, Seattle, USA) was grown in HEp-2 cells in complete medium RPMI 1640 supplemented with heat-inactivated fetal calf serum (Gibco) lo%, 2 mM L-glutamine, vancomycin 25 mg/L, gentamicin 5 mg/L, glucose 1% w/v and cycloheximide 1 pg/ml (i.e. infection medium). Infected cells were harvested after culture for 48 h at 37°C. EB were purified in a discontinuous gradient of Urographin [23] and stored in 100 p1 volumes at -80°C. U937 cells were plated at a density of 1 X 106/cells per well in six-well culture plates and differentiation was induced by adding the phorbol ester 12-0-tetradecanoyl phorbol-13-acetate (TPA) (5 X l Ob9 M) to the culture medium. After 72 h, the differentiated cells were washed once and inoculated with C.
trachomatis at a multiplicity of infection (MOI) of 0.5. Non-infected controls were run in parallel. After centrihgation (20 min, 450 g), the cells were incubated for 2 h at 37°C in CO2 5% and then washed three times with Hanks's Balanced Salts Solution (HBSS) to remove non-ingested bacteria. At various times, cells were harvested by scraping with a rubber scraper and frozen at -80°C for determinations of infectivity and chlamydial rRNA; preparations for immunofluorescence microscopy were made on the day of harvest. As positive controls for chlamydial infectivity, cultures of HEp-2 cells (5 X 105/ml) were infected and harvested as described above.
IFN-y treatment of infected U93 7 culture
Differentiated U937 cells were incubated with IFN-y at 25 (1.25 ng) and 400 (20 ng) U/ml (1 X lo6 U E 50 pg, Biogen) for 24 h. Thereafter, the cells were infected with C. trachomatis and harvested at day 2 post-infection to determine infectivity and the number of inclusions. Treatment of HEp-2 cells with IFN-y at 0.1-400 U/ml and subsequent infection with C.
trachomatis (MOI 0.5) was performed as a control.
Assay for intracellular I D 0 activity
TPA-differentiated U937 cells were treated with or without IFN-y and with or without C. trachomatis and harvested 2, 3 and 5 days after infection. After washing in PBS, the pellets (1 X lo6 cells) were frozen at -70°C. The cell pellets were then thawed and the assay for indoleamine 2,3-deoxygenase (IDO) was performed as described previously [24] . The assay is based on the determination of the decyclisation product of Ltryptophan, kynurenine, that is measured at an absorbance of 490 nm after addition of Ehrlich's reagent (0.4% p-dimethylaminobenzaldehyde/acetic acid). As a positive control IFN-y-stimulated 86HG39 cells (glioblastoma cell line) were used. A strong ID0 activation was found in these cells. They produced > 30 pg of kynurenine/ 1 X lo6 cells.
Determination of the infectious yield of C. trachomatis Culture of cells and infection with C. trachomatis
The infectious yield of C. trachomatis was determined U937 cells from the American Type Culture Collection by titration on HEp-2 cells [25] . Frozen samples of (Rockville, MD, USA) were cultured in RPMI 1640 infected TPA-differentiated U937 cells were thawed in medium with fetal calf serum lo%, 2 mM L-glutamine, an ice-bath and subsequently sonicated for 2 min vancomycin 25 mg/L and gentamicin 5 mg/L (i.e.
(Transsonic 460; Merck, Germany); 50-pl volumes of culture medium) at 37°C in a humidified atmosphere 10-fold dilutions in infection medium were added to with COz 5%.
the HEp-2 cells growing in 96-well microtitration plates. After incubation for 48 h at 37"C, the cultures were fixed with absolute ethanol. Inclusion bodies were stained by an immunoperoxidase assay, with the serum of a C. trachomatis-positive patient having an IgG specific titre of > 256 (Ipazymtest, Medac, Hamburg, Germany), and counted by light microscopy. The results are expressed as infection forming units (IFU)/ml.
Imm unojluorescen ce microscopy
For the direct immunofluorescence microscopy, infected and mock-infected U937 cells (105/100 pl) were centrifuged on to slides and fixed with methanol. Chlamydial inclusion bodies and single bacteria were visualised with an anti-MOMP FITC-conjugated monoclonal antibody (MAb) (Syva, Palo Alto, CA, USA). Brightly shining green inclusions were counted and the results were expressed as inclusion bodies/ 1 O5 cells. For the indirect immunofluorescence assay, TPAdifferentiation of U937 cells was performed on coverslips and cells were infected as described. At different times cultures were air-dried or fixed with methanol and subsequently treated with either the anti-hsp60 MAb GP 51-19 (a generous gift from Dr Morrison, Hamilton, MT, USA) or the anti-LPS MAb S 25-23 (a generous gift from Dr Brade, Borstel, Germany). Bound antibodies were visualised with a second FITC-labelled goat anti-mouse F(ab')2 fragment (Dianova, Hamburg, Germany). All samples were screened with an epifluorescence microscope (Leitz, Wetzlar, Germany).
Determination of chlamydia1 rRNA synthesis
Chlamydial rRNA was determined by an in-vitro hybridisation assay with a single-stranded chemiluminescent-labelled cDNA probe (PACE 2; Gen-probe, San Diego, CA, USA). Samples of infected U937 cells (1-3 X lo5) were resuspended in 100 ,ul of lysis buffer (Gen-probe) and the test was performed according to the manufacturer's instructions. Concentrations of chlamydial rRNA are expressed as relative light units (RLU). In our experience, the test has a detection limit of rRNA corresponding to 50 TFU [ 121.
Transmission electron m icroscopy
Pellets of TPA-differentiated U937 cells (2 X lo6 cells/ pellet) infected with C. trachomatis were harvested at day 7 after infection and fixed in glutaraldehyde 3% in 0. Immunopositive proteins were visualised with alkaline phophatase-conjugated rabbit anti-mouse IgG (Dianova) followed by staining with 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and nitrobluetetrazolium (NBT; both from Sigma). Lanes were analysed with a scanning densitometer (Pharmacia, Freiburg, Germany).
Statistical analysis
Statistical analysis was performed on the mean and SD of independent experiments. The significance of the values was calculated with the non-paired two-tailed Student's t test. A p value < 0.05 was considered to indicate a significant difference between two sets of data.
Results

Infection of U937 cells with C. trachomatis
The fate of C. trachomatis in TPA-differentiated U937 cells was investigated over 14 days. The infection was followed by determination of chlamydial inclusion bodies by immunofluorescence, by titration of cell lysates from infected U937 cells on HEp-2 cells and by measurement of chlamydial rRNA. Cells inoculated with C. trachomatis at an MOI of 0.5 permitted low grade replication over the whole cultivation period without destroying the cell culture ( Fig. la-c) . The number of fluorescent inclusion bodies stained with the anti-MOMP MAb increased gradually from the day of infection to day 7 after infection ( Fig. la) . An additional significant rise in the yield of inclusions was found between day 7 and day 10 after infection (p<O.OOl). At that time, 0.5-2% of the TPAdifferentiated U937 cells contained fluorescent inclusions as shown in Fig. 2 . Single fluorescent chlamydial particles were also observed in cells containing no inclusion bodies. From day 10 to day 14 after infection, the number of inclusions decreased considerably (p < 0.003). Coincident with the increase of inclusion bodies, a rise in the infectious yield of C. trachomatis was observed fkom day 1 to day 7 after infection (p < 0.004) and a decrease of infectivity was apparent from day 7 to day 14 after infection (p<0.002) as determined by titration of the lysates from infected TPA-differentiated U937 cells on HEp-2 cells (Fig. lb) . In control (HEp-2) cells infected at an MOI of 0.5, the yield of C. trachomatis was c. 2.3 loglo higher than in infected U937 cells (Fig. lb) . In contrast to the U937 cells, the monolayer of HEp-2 cells was destroyed after culture for 3 days as observed by immunofluorescence and light microscopy. The amount of chlamydial rRNA that was determined in infected cultures of TPAdifferentiated U937 cells followed a similar time course to the infectivity (Fig. lc) .
Effect of IFN-y
Pretreatment of chlamydiae-infected Hep-2 cells with IFN-y concentrations > 25 U/ml inhibited the development of infective elementary bodies as shown by titration of the cell lysates on HEp-2 cells, whereas lower concentrations of IFN-y still permitted infectivity (Table 1) . Therefore, 25 U of the cytokine/ml were incubated with TPA-differentiated U937 cell 24 h before infection with C. trachomatis. As shown in Table 1 , the production of infectious chlamydiae and the development of inclusions in U937 cells was not altered by this concentration. Pre-incubation with IFN-y at 400 U/ml also did not result in a decrease in the number of IFU or fluorescent inclusion bodies.
IFN-y treatment has been shown to induce the expression of IDO, that converts L-tryptophan to kynurenine. It has been proposed that IFN-mediated chlamydial persistence arises from enhanced I D 0 expression and subsequent tryptophan depletion. However, this enzyme was not found to be induced in U937 cells by either IFN-y or chlamydiae or both together (data not shown), whereas in the positive control (IFN-y-treated 86HG39 cells), strong ID0 activity was measured.
Electron microscopy
Only few (1-2%) of the TPA-differentiated U937 cells that were examined 7 days after incubation with C. trachomatis at a MOI of 0.5 contained a typical inclusion body with numerous EB, RB and intermediate forms (Fig. 3a) . However, > 80% of the U937 cells contained vacuoles in which one or two chlamydiae were present. The bacteria within the vacuoles often had an enlarged shape containing electron-dense material and resembled EB or intermediate forms but not RB (Fig. 3b) . In mock-infected U937 cells, no such structures were observed.
Expression of chlamydial antigens
To determine levels of chlamydial antigens during persistent infection of U937 cells, three were selected for evaluation: the MOMP antigen, a target of neutralising antibodies (the major vaccine antigen); LPS, a major antigen on the chlamydial surface; and the hsp60 antigen, chosen because the immune response to this protein may be important in the immunopathogenesis of persistent inflammation [22, 29-3 I] . Immunoblotting and immunofluorescence were used to compare the amounts and localisation of MOMP, LPS' and hsp60 in infected U937 cells. Densitometer tracings of immunoblots of cells 48 h after infection indicated a 6.5:l ratio of hsp60 to MOMP (Fig. 4, lane A) and a nearly 8.6:l ratio of hsp60 to MOMP (Fig. 4 , lanes C, D, E) in cells 7, 10 and 14 days after infection. The 5.7:l ratio of hsp60 to MOMP in isolated elementary bodies corresponds to the ratio in infected cells 48 h after infection. The level of the chlamydial LPS slightly increased during infection of U937 cells.
Immunofluorescence with the anti-LPS MAb gave an intense staining on the surface of the air-dried U937 cells at every time-point of the culture, whereas the anti-hsp60 MAb stained only the inclusions in the airdried cells (Fig. 5a, b) . In infected U937 cells that were fixed with methanol, only chlamydial inclusions were stained with the anti-LPS MAb or with the antihsp60 MAb (not shown). No staining was observed with either mock-infected U937 cells or the second antibody alone.
Discussion
Persistent infection by C. trachomatis has been studied in a limited number of cell culture systems and most experiments have been performed in fibroblasts or epithelial cells [20, 21, 321 . However, these cells are not the only important host cells in vivo, because increasing evidence shows that 'professional' phagocytes play a decisive role in the persistence of chronic chlamydial infections [13, 14, 331. It has been proposed that monocytes act as vehicles for chlamydial dissemination in the infected host and serve as reservoirs of antigens that trigger the inflammatory response [34-361. A persistent infection of C. trachomatis was established in the monocytic cell line U937 under nonlimiting growth conditions, i.e., in the absence of inhibitors or deficiencies. This cell culture system differs from the established host-parasite system with biphasic cycles of McCoy cells and C. trachomatis introduced by Lee and Moulder [32] . The present study showed that TPA-differentiated U937 cells became persistently infected after inoculation at a low and nondestructive MOI with the chlamydial urogenital strain serovar K. Clearly the transition from infected host cells to new host cells was low and, therefore, over a period of 14 days a co-existence or balance between chlamydial development and intact live cell culture was maintained. It is important to note that only 0.5-2% of the U937 cells contained inclusion bodies at the time when chlamydial infectivity and replication were at a maximum, i.e. day 7 until day 10 after infection.
However, > 80% of these cells contained chlamydiae differing in ultrastructure from the typical EB and RB present in inclusion bodies. This observation may explain the observation of single fluorescent particles by immunofluorescence microscopy. The atypical EB- observation indicates that, depending on the host cell, the replication of chlamydiae is permitted, retarded or inhibited.
In vivo, the intracellular pathogen is sheltered from direct immune attack, but it remains susceptible to the cytokine-mediated immune response. 
